Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for lower extremity perfusion in diabetic patients at high risk of diabetic foot ulcer
IRCT20180818040823N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pentoxifylline in diabetes mellitus (DM), sponsored by Tehran University of Medical Sciences. Primary endpoints: Improvement of lower extremity perfusion and Quantitative muscle perfusion change. Started Mar 2019; status: completed.
02
Drugs
pentoxifylline
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on IRCT20180818040823N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180818040823N1.